Cheryl Xu

CIK: 0001976957

Transaction Breakdown

Open Market Buys (P)10 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SXTP

60 DEGREES PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SXTP
60 DEGREES PHARMACEUTICALS, INC.
Jun 3, 2025
Purchase(P)
Direct
3K shares at avg. $2.87$9K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Jun 3, 2025
Purchase(P)
Direct
2K shares at avg. $2.90$6K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 16, 2024
Purchase(P)
Direct
2K shares at avg. $1.45$3K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 13, 2024
Purchase(P)
Direct
1.5K shares at avg. $1.58$2K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 13, 2024
Purchase(P)
Direct
1.5K shares at avg. $1.60$2K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 13, 2024
Purchase(P)
Direct
1.5K shares at avg. $1.55$2K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 13, 2024
Purchase(P)
Direct
1.5K shares at avg. $1.52$2K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 12, 2024
Purchase(P)
Direct
2.5K shares at avg. $1.80$5K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Dec 12, 2024
Purchase(P)
Direct
2.5K shares at avg. $1.85$5K
SXTP
60 DEGREES PHARMACEUTICALS, INC.
Aug 27, 2024
Purchase(P)
Direct
5K shares at avg. $1.70$9K

		Type	Shares	Price		Ownership
Jun 3, 2025	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	3,000	$2.87	$8,610	Direct
Jun 3, 2025	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	2,000	$2.90	$5,800	Direct
Dec 16, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	2,000	$1.45	$2,900	Direct
Dec 13, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	1,500	$1.58	$2,370	Direct
Dec 13, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	1,500	$1.60	$2,400	Direct
Dec 13, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	1,500	$1.55	$2,325	Direct
Dec 13, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	1,500	$1.52	$2,280	Direct
Dec 12, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	2,500	$1.80	$4,500	Direct
Dec 12, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	2,500	$1.85	$4,625	Direct
Aug 27, 2024	SXTP 60 DEGREES PHARMACEUTICALS, INC.	Purchase(P)	5,000	$1.70	$8,500	Direct

1-10 of 10 transactions

About XU CHERYL

XU CHERYL (SEC CIK 0001976957) files insider reports with the SEC as Director of 60 DEGREES PHARMACEUTICALS, INC. (SXTP).

Signal8 holds 3 ownership filings by XU CHERYL, all Form 4s, filed between Sep 11, 2024 and Jun 5, 2025. Those filings report 10 transactions, from Aug 27, 2024 to Jun 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on XU CHERYL's filings is in WASHINGTON, DC.

Recent filings by XU CHERYL

Jun 3, 2025: Open-market purchases of SXTP shares (2 lines, Form 4, code P).
Dec 16, 2024: Open-market purchase of SXTP shares (Form 4, code P).
Dec 13, 2024: Open-market purchases of SXTP shares (4 lines, Form 4, code P).
Dec 12, 2024: Open-market purchases of SXTP shares (2 lines, Form 4, code P).
Aug 27, 2024: Open-market purchase of SXTP shares (Form 4, code P).

Other insiders filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Knight Therapeutics Inc., 10% Owner
DOW GEOFFREY S, President and CEO
Francois Eric, Director
Landon Kristen, Chief Operating Officer
MILLER TYRONE, CFO

How to read Form 4 transaction codes